Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World StudyAlessandro Conforti, Alarico Ariani, Martina Gentile, et al.
Rheumatology and Therapy|March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic ArthritisValentino Paci, Alarico Ariani, Eleonora Celletti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
RMD Open|December 6, 2023
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registryAntonio Vitale, Valeria Caggiano, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Rheumatology (Oxford, England)|September 30, 2025
Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease RegistryLaura Calabrese, Martina D'Onghia, Alessandra Cartocci, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Rheumatology (Oxford, England)|November 19, 2025
Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network RegistryAntonio Vitale, Francesco Gavioli, Valeria Caggiano, et al.
Pageof 8